Ignite Creation Date:
2025-12-18 @ 9:57 AM
Ignite Modification Date:
2025-12-18 @ 9:57 AM
Study NCT ID:
NCT02702414
Status:
None
Last Update Posted:
2024-09-04 00:00:00
First Post:
2016-03-03 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-29
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-03 00:00:00
First Submit QC Date:
None
Study First Post Date:
2016-03-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-07 00:00:00
Results First Submit QC Date:
None
Results First Post Date:
2022-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-09 00:00:00
Last Update Post Date:
2024-09-04 00:00:00
Last Update Post Date Type:
ACTUAL